Speeding up the Standards Process
It can easily take the same amount of time to create a standard and bring a new medicine to market. It takes around ten years, the experts typically say. The problem now is that most of us can appreciate that it takes years to develop a cancer medicine, get the product through clinical trials, and bring it to the market. The argument for why it can take ten years to put together an alpha-numeric code to identify an instrument or an entity, or simply agree on a format to publish data in, is a tad less convincing.
The global nature of financial markets was highlighted during the financial crisis, and it has led to a growing realization that there is a need for standardized, international data that can easily be analyzed. The challenge now is for regulators and the industry to agree on how to do this. At recent industry events, market practitioners have suggested we have to stop talking about the standards problem, and instead come together to actually agree on standards that can be adopted. It has been suggested that perhaps around five large firms can team-up, agree on the best way forward, and become the early adopters.
There might not be much time to discuss if this is the best approach, or if someone has any better ideas. The regulators seem to be running out of patience. At the public hearing on the Markets in Financial Instruments Directive in Brussels in September, Sharon Bowles, who chairs the Economic and Monetary Affairs Committee in the European Parliament, talked about the data problem, saying: "We really must have coordination and some regulatory intervention seems inevitable to push firmly on the outstanding barriers to make sure that it gets done in a sufficiently rapid timeframe."
But Bowles also recognized that the expertise is in the industry. This has been the message for some time now. Regulators want the industry to create the standards. The problem seems to be that the process is too slow. There are now talks about standards bodies and industry associations cooperating, and there constantly seems to be something happening. The issue is perhaps simply that standards-setting takes time.
Regulators do not have time. They want to prevent the next crisis, and waiting for a ten-year standards process may not help the political agenda. It may also be slightly difficult to comprehend that it can take as long to create a standard as it can for a biochemical company to get sometimes life-saving medicines to the ill. The question now is if market practitioners will settle with the fact that this is how it is, or if someone will now take leadership, and get this party started.
For Inside Reference Data and Inside Market Data, the party will be in Hong Kong this month, where we, together with the FISD, have our annual Asia-Pacific Financial Information Conference, including an off-site dinner and a horse-racing evening.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Regulation
Waters Wavelength Ep. 341: Citi’s Pitts and Topa
This week, Citi’s Michele Pitts and Marcello Topa join Wei-Shen to talk about UK and EU T+1.
Why source code access is critical to DORA compliance
As DORA takes hold in EU, Adaptive’s Kevin Covington says that it is shining a light on the criticality of having access to source code.
Nasdaq’s blockchain proposal to SEC gets mixed reviews from peers
Public comment letters and interviews reveal that despite fervor for tokenization, industry stakeholders disagree on its value proposition.
FCA files to lift UK bond tape suspension, says legal claims ‘without merit’
After losing the bid for the UK’s bond CT, Ediphy sued the UK regulator, halting the tape’s implementation. Now, the FCA is asking the UK’s High Court to end the suspension and allow it to fight Ediphy’s claims in parallel.
Treasury market urged to beef up operational resilience plans
NY Fed panel warns about impact of AI and reliance on critical third parties.
Technology alone is not enough for Europe’s T+1 push
Testing will be a key component of a successful implementation. However, the respective taskforces have yet to release more details on the testing schedules.
Waters Wavelength Ep. 338: BBH’s Mike McGovern
This week, Mike McGovern of Brown Brothers Harriman talks with Tony about the importance of open architectures and the need for better data management in this increasingly AI-driven world.
Plaintiffs propose to represent all non-database Cusip licensees in last 7 years
If granted, the recent motion for class certification in the ongoing case against Cusip Global Services would allow end-user firms and third-party data vendors alike to join the lawsuit.